Artigo de periodico

Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA) (2013)

• Authors:
  • Schneeweiss, A.
  • Chia, S.
  • Hickish, T.
  • Harvey, V.
  • Eniu, A.
  • Hegg, R.
  • Tausch, C.
  • Seo, J. H.
  • Tsai, Y.-F.
  • Ratnayake, J.
  • McNally, V.
  • Ross, G.
  • Cortés, J.
• Autor USP: HEGG, ROBERTO - FM
• Unidade: FM
• DOI: 10.1093/annonc/mdt182
• Subjects: NEOPLASIAS MAMÁRIAS (DIAGNÓSTICO;QUIMIOTERAPIA); ANTINEOPLÁSICOS (DIAGNÓSTICO)
• Language: Inglês
• Imprenta:
  • Publisher place: Oxford
  • Date published: 2013
• Source:
  • Título do periódico: Annals of Oncology
  • ISSN: 0923-7534
  • Volume/Número/Paginação/Ano: v. 24, n. 9, p. 2278-2284, 2013

Informações sobre o DOI: 10.1093/annonc/mdt182 (Fonte: oaDOI API)
• Este periódico é de assinatura
• Este artigo é de acesso aberto
• URL de acesso aberto
• Cor do Acesso Aberto: hybrid
• Licença: publisher-specific-oa

---

How to cite

A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

• ABNT

  SCHNEEWEISS, A. et al. Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA). Annals of Oncology, v. 24, n. 9, p. 2278-2284, 2013Tradução . . Disponível em: https://doi.org/10.1093/annonc/mdt182. Acesso em: 25 abr. 2024.

• APA

  Schneeweiss, A., Chia, S., Hickish, T., Harvey, V., Eniu, A., Hegg, R., et al. (2013). Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA). Annals of Oncology, 24( 9), 2278-2284. doi:10.1093/annonc/mdt182

• NLM

  Schneeweiss A, Chia S, Hickish T, Harvey V, Eniu A, Hegg R, Tausch C, Seo JH, Tsai Y-F, Ratnayake J, McNally V, Ross G, Cortés J. Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA) [Internet]. Annals of Oncology. 2013 ; 24( 9): 2278-2284.[citado 2024 abr. 25 ] Available from: https://doi.org/10.1093/annonc/mdt182

• Vancouver

  Schneeweiss A, Chia S, Hickish T, Harvey V, Eniu A, Hegg R, Tausch C, Seo JH, Tsai Y-F, Ratnayake J, McNally V, Ross G, Cortés J. Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: A randomized phase II cardiac safety study (TRYPHAENA) [Internet]. Annals of Oncology. 2013 ; 24( 9): 2278-2284.[citado 2024 abr. 25 ] Available from: https://doi.org/10.1093/annonc/mdt182

Últimas obras dos mesmos autores vinculados com a USP cadastradas na BDPI:

• Galactorreia: sindrome hiperprolactinemica
• Como diagnosticar e tratar sindrome do climaterio
• Hormonioterapia de reposicao e cancer de mama
• Prevencao da osteoporose
• Câncer de mama
• Recursos terapêuticos na doente terminal
• Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
• Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4
• Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
• Distrofias vulvares